I think it's a great question.
By educating people in vulnerable sectors, especially now in the COVID context, if we use the biopharma example, that education piece and that outreach is critical for these companies to know and be aware when they might be vulnerable to attack.
Once they are armed with that information, they can start to spot signs and then they can get in touch with the government to say they think something is going on here and you might want to review this. That education piece kick-starts everything, because we're only alive to the threats when they're brought to our attention. That's the importance of that outreach.